Urinary C6-C12 dicarboxylic acylcarnitines in Reye's syndrome.
C6-C12 dicarboxylic acylcarnitines have been identified for the first time in urine from a 2-year-old girl presenting with Reye's syndrome. The acylcarnitines were extracted by ion-exchange chromatography and analysed, both underivatised and as methyl esters using high-resolution fast-atom-bombardment mass spectrometry and B/E-linked scanning. The acylcarnitines were quantified by capillary gas chromatography of the acids extracted after hydrolysis of the acylcarnitine esters. Dodecandioylcarnitine was present in the highest concentration (35.9 mmol/mol creatinine) which exceeded the urinary free dodecandioic acid concentration. The adipic, suberic and sebacic acylcarnitine concentrations were less than 10% of the respective free acid concentrations. It is possible that beta-oxidation of dicarboxylic acids is partially inhibited in Reye's syndrome leading to accumulation of precursor dodecandioyl CoA which is metabolised to dodecandioylcarnitine. The accumulation of these metabolic intermediates may be significant in the pathogenesis of Reye's syndrome.
Tracey
B M
BM
Perinatal and Child Health, MRC Clinical Research Centre, Harrow, Middlesex, UK.
Cheng
K N
KN
Rosankiewicz
J
J
Stacey
T E
TE
Chalmers
R A
RA
D002331:Carnitine / Q000652:urine*; D002675:Child, Preschool; D003998:Dicarboxylic Acids / Q000652:urine*; D005260:Female; D006801:Humans; D012202:Reye Syndrome / Q000652:urine*
D003998:Dicarboxylic Acids; D002331:Carnitine